Education
About Us
Working with TipRanks
Follow Us
Century Therapeutics, Inc. (IPSC)
:IPSC
Il-2, Cnty-101, Lymphodepleting Chemotherapy
Lupus Nephritis, Systemic Lupus Erythematosus, Diffuse Cutaneous Systemic Sclerosis, Idiopathic Inflammatory Myopathies
Phase I
Recruiting
A Study of CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune Diseases
Feb 05, 2024
―
Il-2, Cnty-101, Lymphodepleting Chemotherapy
Indolent Non-Hodgkin Lymphoma, R/R Cd19-Positive B-Cell Malignancies, Aggressive Non-Hodgkin Lymphoma
Phase I
Active Not Recruiting
A Study of CNTY-101 in Participants With CD19-Positive B-Cell Malignancies
Apr 08, 2022
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Century Therapeutics, Inc. (IPSC) have in its pipeline
IPSC is currently developing the following drugs: Il-2, Cnty-101, Lymphodepleting Chemotherapy, Il-2, Cnty-101, Lymphodepleting Chemotherapy. These drug candidates are in various stages of clinical development as the company works toward FDA approval.